Published

Balancing safety and access in Oregon’s psilocybin services

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: International Journal of Drug Policy
Date: 2026-09-01
Source: Crossref
DOI: 10.1016/j.drugpo.2026.105384
PubMed: 42288041

Authors

Cheung Katherine Propes Caleigh Yaden David B.

Watch author

Derived topics and classifications

psilocybin Safety Other

Citation graph

15 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1038/s41380-023-02360-0 10.1215/10539867-12110802 10.2105/ajph.2024.307874 10.1371/journal.pone.0293349 10.1177/02698811241292951 10.1080/15265161.2024.2433423 10.1556/2054.2026.00485 10.1001/jamapsychiatry.2024.2546 10.1080/15265161.2024.2342764 10.1017/jme.2025.30 10.1001/jamapsychiatry.2023.0099 10.1001/jamahealthforum.2025.4928

Indexed papers citing this DOI

Balancing safety and access in Oregon’s psilocybin services2026-09-01

Related papers

The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young AdultsClinicalTrials.gov · 2026-08-14 The Experience-Trajectory Framework: Substance-Specific Risk Stratification for Psychedelic Preparation and Aftercare Beyond Set and SettingInternational Journal For Multidisciplinary Research · 2026-07-31 Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01 Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01 Assessing Canadian Policy Readiness for Psychedelic-Assisted Therapy in Cancer CareUnknown journal · 2026-08-17 Safety for Home Administration of Microdose Psilocybin UseClinicalTrials.gov · 2026-08-14 Processing Intergenerational Trauma With Psilocybin-Assisted TherapyClinicalTrials.gov · 2026-08-13 PsiloStudy: A Phase 2 Single-site, Double-blind, Placebo-controlled, Randomized Clinical Trial With an Open-label Extension Phase to Examine the Safety, Subjective Experiences, Acute Effects, and Suitability of Psilocybin Combined With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD)ClinicalTrials.gov · 2026-08-13